Jin J et al. Homoharringtonine-based induction regimens for patients with de novo acute myeloid leukemia: A multicenter randomized controlled Phase 3 trial. Proc ASH 2012;Abstract 45.

Dr Talpaz is Alexander J Trotman Professor of Leukemia Research, Associate Director of Translational Research at UM Comprehensive Cancer Center, Associate Chief of the Division of Hematology/Oncology and Director of Hematologic Malignancies at the University of Michigan Medical Center in Ann Arbor, Michigan.